CG Oncology (CGON) Prepaid Assets (2023 - 2026)

CG Oncology has reported Prepaid Assets for 4 years, with the latest figure at $23.1 million in Q1 2026.

• For the quarter ending Q1 2026, Prepaid Assets rose 86.36% year-over-year to $23.1 million; the trailing twelve-month figure through Mar 2026 stood at $23.1 million (up 86.36% YoY), and the FY2025 full-year result was $15.1 million, up 23.38% from the prior year.
• Prepaid Assets for Q1 2026 stood at $23.1 million, up from $15.1 million in the prior quarter.
• The five-year high for Prepaid Assets was $23.1 million in Q1 2026, with the low at $6.4 million in Q4 2023.
• Historically, Prepaid Assets has averaged $12.8 million across 4 years, with a median of $12.1 million in 2024.
• Annual changes were most pronounced in 2024 — Prepaid Assets jumped 92.07% — and 2025, when it increased 3.88%.
• CG Oncology's Prepaid Assets stood at $6.4 million in 2023, then jumped by 92.07% to $12.2 million in 2024, then advanced by 23.38% to $15.1 million in 2025, then jumped by 53.53% to $23.1 million in 2026.
• The last three Prepaid Assets figures came in at $23.1 million (Q1 2026), $15.1 million (Q4 2025), and $13.5 million (Q3 2025), per Business Quant data.